StemCells, Inc. (NASDAQ:STEM)
CAPS Rating:
A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.
A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.
Recs
The last stock I add to MYCAPS based on another user's predictions - all I gotta say. Will drop this stock from caps list as soon as my minimum 7 day is met.